iFight PID Fund organized a Cultural Duo fundraising concert to support its mission: “Every child with PID should have the chance to live”

iFight PID Fund organized a Cultural Duo fundraising concert to support its mission: “Every child with PID should have the chance to live”

People at Conference

Beirut, November 19, 2018 – Following its launch in 2017, the iFight PID Fund, a volunteer initiative which benefits children diagnosed with Primary Immunodeficiency Diseases (PID) at the American University of Beirut Medical Center (AUBMC) in collaboration with the American University of Beirut (AUB), organized a Cultural Duo Guitar and Flute fundraising concert at AUB’s Assembly Hall. The proceedings of the concert will contribute to fulfill the mission of the initiative: Every child with PID should have the chance to live.

The event was attended by Mrs. Ola Masri Joumblatt, Founder and President of the iFight PID Fund, Prof. Ghassan Dbaibo, Director of the Center for Infectious Diseases Research, Director of the National Neonatal Screening Program for Primary Immunodeficiency Diseases (NaSPID) and member at the iFight PID Fund along with AUBMC Volunteer Group members and senior AUB and AUBMC healthcare practitioners and staff.

“Around 60 to 65 children are born in Lebanon every year with severe cases of PIDs, which makes the disorder almost as common as the annual number of new cases of cancer diagnosis among children. Unfortunately, many of these children die before they even get to be appropriately diagnosed and treated,” highlighted Mrs. Ola Masri Joumblatt. “With early diagnosis, proper care and optimal treatment, PID is manageable and can save children from lifelong disabilities, unnecessary vaccinations and lengthy hospital visits. Our aim is to help improve patients’ conditions so they live full and rewarding lives,” concluded Mrs. Joumblatt.

The global incidence of PIDs varies. In the USA for example, it is estimated that 1 in 1200 children has a PID that significantly affects their health. However, lack of awareness means that globally between 70 to 90 per cent of people affected remain undiagnosed, with their healthcare practitioners treating primary immune deficiency related infections as common flus (1). Although there are no accurate figures in Lebanon and the Middle East, the rate is estimated to be 5 to 10 times higher due to intermarriage. If the rate is at least like the USA, then it is expected that 60 to 65 Lebanese children and perhaps another 25 to 30 Syrian children are born with PID in Lebanon every year. Currently, these children go to different centers in Lebanon and are not always evaluated by PID specialists. Many of them die before they are diagnosed.

“Our mission is to support children with PID through enhancing screening and facilitating diagnosis and treatment to patients with primary immunodeficiencies,” said Prof. Ghassan. “Our continuous efforts are a testimony to reinforcing the future vision of establishing a comprehensive specialized center for PID in addition to supporting advanced research to help protect our community,” he added.

Upon its establishment in 2017, iFight PID Fund with the endorsement of the Ministry of Public Health (MoPH) launched the National Program of Neonatal Screening for Primary Immunodeficiency Diseases (NaSPID), a preventive public health program that is carried out in many countries across the World. Supported by MoPH, supervised by iFight PID Fund and directed at the Center for Infectious Diseases Research (CIDR) at AUBMC, NaSPID is the first such program in the MENA region. It enables early identification of some of the severe forms of PID that, without detection and treatment, can lead to death at an early age in affected children.

Starting April 2018, all Lebanese hospitals became obliged to conduct PID screening test on each newborn in Lebanon. Such a procedure will have a positive impact on decreasing the number of infant mortality and will help iFight PID Fund get accurate data. The testing is done in coordination with AUBMC and Université Saint Joseph, Medical Genetics Unit.




Since 1902, AUBMC has been providing the highest standards of care to patients across Lebanon and the region. It is also the teaching hospital for the Faculty of Medicine at AUB (established in 1867), which has trained generations of medical students and physicians, and whose graduates can be found at leading institutions around the world. AUBMC is the only medical institution in the Middle East to have earned the five international accreditations of JCI, Magnet, CAP, ACGME-I and JACIE attesting to its superior standards in patient-centered care, nursing, pathology/laboratory services and graduate medical education.

The Faculty of Medicine has graduated over 4,000 medical students and physicians; the Rafic Hariri School of Nursing provides excellent education for the nursing staff, and the Medical Center meets the healthcare needs of over 360,000 patient visits annually.

For more information, please visit our website www.aubmc.org or contact:

The AUBMC Office of Communications at 0096 1 350000 ext. 4732 – Email: praubmc@aub.edu.lb

Memac Ogilvy Public Relations at 01-486065 ext.131

Carmen El Hajj/ Hadi Al Attar – hadi.alattar@ogilvy.com